Pulse wave amplitude drops (PWAD) index: a biomarker of cardiovascular risk in patients with obstructive sleep apnea in three cohorts.

G. Solelhac (Lausanne, Switzerland), M. Sánchez-De-La-Torre (Lleida, Spain), M. Blanchard (Angers, France), M. Berger (Lausanne, Switzerland), N. Marchi (Lausanne, Switzerland), C. Hirotsu (Lausanne, Switzerland), G. Bernardi (Lucca, Italy), M. Betta (Lucca, Italy), P. Vollenweider (Lausanne, Switzerland), J. Vaucher (Lausanne, Switzerland), A. Zapater (Lleida, Spain), E. Gracia-Lavedan (Lleida, Spain), P. Marques-Vidal (Lausanne, Switzerland), F. Barbé (Lleida, Spain), F. Gagnadoux (Angers, France), R. Heinzer (Lausanne, Switzerland)

Source: International Congress 2022 – Obstructive sleep apnea consequences and management
Session: Obstructive sleep apnea consequences and management
Session type: Oral Presentation
Number: 2284

Congress or journal article abstractWebcastPDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Solelhac (Lausanne, Switzerland), M. Sánchez-De-La-Torre (Lleida, Spain), M. Blanchard (Angers, France), M. Berger (Lausanne, Switzerland), N. Marchi (Lausanne, Switzerland), C. Hirotsu (Lausanne, Switzerland), G. Bernardi (Lucca, Italy), M. Betta (Lucca, Italy), P. Vollenweider (Lausanne, Switzerland), J. Vaucher (Lausanne, Switzerland), A. Zapater (Lleida, Spain), E. Gracia-Lavedan (Lleida, Spain), P. Marques-Vidal (Lausanne, Switzerland), F. Barbé (Lleida, Spain), F. Gagnadoux (Angers, France), R. Heinzer (Lausanne, Switzerland). Pulse wave amplitude drops (PWAD) index: a biomarker of cardiovascular risk in patients with obstructive sleep apnea in three cohorts.. 2284

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.